Bioceres Crop Solutions (NASDAQ:BIOX) Given New $9.50 Price Target at Canaccord Genuity Group

Bioceres Crop Solutions (NASDAQ:BIOX) had its target price lowered by Canaccord Genuity Group from $10.00 to $9.50 in a research note published on Wednesday morning,Benzinga reports. The firm currently has a buy rating on the stock.

Other research analysts have also recently issued research reports about the stock. Oppenheimer lowered their target price on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, October 21st. Canaccord Genuity Group raised Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Roth Mkm decreased their target price on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Finally, Lake Street Capital lowered their price target on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Four research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Bioceres Crop Solutions presently has an average rating of “Buy” and an average target price of $12.13.

Bioceres Crop Solutions Stock Down 3.9 %

Shares of BIOX stock opened at $6.17 on Wednesday. The company has a 50 day simple moving average of $7.50 and a two-hundred day simple moving average of $9.75. The stock has a market cap of $387.78 million, a P/E ratio of 308.65 and a beta of 0.49. Bioceres Crop Solutions has a 12 month low of $5.71 and a 12 month high of $14.05. The company has a current ratio of 1.27, a quick ratio of 0.86 and a debt-to-equity ratio of 0.37.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The company had revenue of $92.60 million for the quarter, compared to the consensus estimate of $117.15 million. During the same period in the prior year, the firm posted ($0.07) EPS. On average, research analysts expect that Bioceres Crop Solutions will post 0.33 earnings per share for the current year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Hedge funds have recently made changes to their positions in the company. Stifel Financial Corp grew its holdings in Bioceres Crop Solutions by 33.4% during the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after buying an additional 10,224 shares in the last quarter. Fourth Sail Capital LP increased its position in Bioceres Crop Solutions by 61.6% during the third quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock valued at $24,957,000 after acquiring an additional 1,209,277 shares during the last quarter. Long Focus Capital Management LLC lifted its holdings in shares of Bioceres Crop Solutions by 19.9% in the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock worth $3,145,000 after acquiring an additional 46,647 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Bioceres Crop Solutions by 9.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after purchasing an additional 5,341 shares during the period. Finally, Ping Capital Management Inc. bought a new position in Bioceres Crop Solutions during the 2nd quarter valued at about $448,000. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.